{"id":246978,"date":"2026-09-15T14:07:43","date_gmt":"2026-09-15T08:37:43","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=246978"},"modified":"2026-09-15T14:07:43","modified_gmt":"2026-09-15T08:37:43","slug":"emcure-pharmaceuticals-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/","title":{"rendered":"Is Emcure Pharmaceuticals the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Emcure Pharmaceuticals CMP Rs 2,004 (15 Sep 2026). Market cap Rs 37,499 Cr. ROE 18.67%. P\/E 36.80x versus Industry P\/E 37.96x.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Emcure Pharmaceuticals is one of the names investors compare when screening the Healthcare sector, built on a 18.67% return on equity and a P\/E of 36.80x against an Industry P\/E of 37.96x. Emcure Pharmaceuticals Ltd develops and manufactures formulations across therapeutic areas including gynaecology, HIV and cardiology, with a presence in India and over 70 export markets. Whether Emcure Pharmaceuticals is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n<p>Is <a href=\"https:\/\/univest.in\/stocks\/emcure\/emcure-pharmaceuticals-ltd-share-price-today\">Emcure Pharmaceuticals<\/a> the best stock in its sector? The stock trades on the NSE at Rs 2,004 as of 15 September 2026, within its 52-week range of Rs 1,260.00 to Rs 2,048.00. Emcure Pharmaceuticals Ltd develops and manufactures formulations across therapeutic areas including gynaecology, HIV and cardiology, with a presence in India and over 70 export markets.<\/p>\n<p>Emcure Pharmaceuticals sits in the Healthcare sector, and its 18.67% ROE and 36.80x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector&#8217;s Industry P\/E benchmark.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/abbott-india-best-stock-in-its-sector\">Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=emcure-pharmaceuticals-best-stock-in-its-sector\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#About_Emcure_Pharmaceuticals\" title=\"About Emcure Pharmaceuticals\">About Emcure Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#Is_Emcure_Pharmaceuticals_the_Best_Stock_in_Its_Sector\" title=\"Is Emcure Pharmaceuticals the Best Stock in Its Sector?\">Is Emcure Pharmaceuticals the Best Stock in Its Sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#How_Emcure_Pharmaceuticals_Compares_Against_Its_Healthcare_Sector_Peers\" title=\"How Emcure Pharmaceuticals Compares Against Its Healthcare Sector Peers\">How Emcure Pharmaceuticals Compares Against Its Healthcare Sector Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#What_Makes_Emcure_Pharmaceuticals_Worth_Watching_in_Healthcare\" title=\"What Makes Emcure Pharmaceuticals Worth Watching in Healthcare\">What Makes Emcure Pharmaceuticals Worth Watching in Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#Emcure_Pharmaceuticals_Valuation_Is_It_Justified\" title=\"Emcure Pharmaceuticals Valuation: Is It Justified?\">Emcure Pharmaceuticals Valuation: Is It Justified?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#How_to_Track_Emcure_Pharmaceuticals_Before_You_Invest\" title=\"How to Track Emcure Pharmaceuticals Before You Invest\">How to Track Emcure Pharmaceuticals Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#Is_Emcure_Pharmaceuticals_the_best_stock_in_its_sector\" title=\"Is Emcure Pharmaceuticals the best stock in its sector?\">Is Emcure Pharmaceuticals the best stock in its sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#What_is_the_current_share_price_of_Emcure_Pharmaceuticals\" title=\"What is the current share price of Emcure Pharmaceuticals?\">What is the current share price of Emcure Pharmaceuticals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#What_sector_does_Emcure_Pharmaceuticals_belong_to\" title=\"What sector does Emcure Pharmaceuticals belong to?\">What sector does Emcure Pharmaceuticals belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#How_does_Emcure_Pharmaceuticals_compare_to_its_sector_peers_on_PE\" title=\"How does Emcure Pharmaceuticals compare to its sector peers on P\/E?\">How does Emcure Pharmaceuticals compare to its sector peers on P\/E?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#What_is_Emcure_Pharmaceuticalss_return_on_equity\" title=\"What is Emcure Pharmaceuticals&#8217;s return on equity?\">What is Emcure Pharmaceuticals&#8217;s return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-best-stock-in-its-sector\/#Should_I_invest_in_Emcure_Pharmaceuticals_based_on_its_sector_position\" title=\"Should I invest in Emcure Pharmaceuticals based on its sector position?\">Should I invest in Emcure Pharmaceuticals based on its sector position?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Emcure_Pharmaceuticals\"><\/span><strong>About Emcure Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Emcure Pharmaceuticals Ltd develops and manufactures formulations across therapeutic areas including gynaecology, HIV and cardiology, with a presence in India and over 70 export markets. At a market capitalisation of Rs 37,499 Cr, it is tracked as part of the Healthcare sector on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Emcure_Pharmaceuticals_the_Best_Stock_in_Its_Sector\"><\/span><strong>Is Emcure Pharmaceuticals the Best Stock in Its Sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Emcure Pharmaceuticals makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 18.67% ROE with a 36.80x P\/E against the sector&#8217;s 37.96x Industry P\/E. Emcure Pharmaceuticals trades almost exactly at its 37.96x Industry P\/E, with an 18.67% ROE that compares reasonably against the larger MNC pharma peers used elsewhere in this series.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Metric<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Emcure Pharmaceuticals<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">CMP (NSE)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 2,004.50<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">52-Week High \/ Low<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 2,048.00 \/ Rs 1,260.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Market Cap<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 37,499 Cr<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/E (TTM) vs Industry P\/E<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">36.80x vs 37.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/B<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">7.58<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">ROE<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">18.67%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">EPS (TTM)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 53.71<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Dividend Yield<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.18%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Debt to Equity<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.31<\/td>\n<\/tr>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Emcure Pharmaceuticals Against Other Healthcare Sector Stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Emcure_Pharmaceuticals_Compares_Against_Its_Healthcare_Sector_Peers\"><\/span><strong>How Emcure Pharmaceuticals Compares Against Its Healthcare Sector Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets Emcure Pharmaceuticals against 3 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P\/E, ROE and debt to equity, calculated across the 3 peer companies.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">P\/E<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/emcure\/emcure-pharmaceuticals-ltd-share-price-today\">Emcure Pharmaceuticals<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">37,499<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">36.80<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">18.67%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/pfizer\/pfizer-ltd-share-price-today\">Pfizer<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">18,583<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">25.28<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">17.19%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sanofiind\/sanofi-india-ltd-share-price-today\">Sanofi India<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">7,093<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">21.91<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">39.20%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">GlaxoSmithKline Pharmaceuticals<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">48,064<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">45.00<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">45.69%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>Peer average (3 companies)<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">&#8211;<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>30.73<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>34.03%<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>0.02<\/strong><\/td>\n<\/tr>\n<\/table>\n<p>Against this peer set, Emcure Pharmaceuticals&#8217;s 18.67% ROE is below the 34.03% peer average, and its P\/E of 36.80x runs above the peer average of 30.73x. Emcure Pharmaceuticals trades almost exactly at its 37.96x Industry P\/E, with an 18.67% ROE that compares reasonably against the larger MNC pharma peers used elsewhere in this series.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Makes_Emcure_Pharmaceuticals_Worth_Watching_in_Healthcare\"><\/span><strong>What Makes Emcure Pharmaceuticals Worth Watching in Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Close to Industry P\/E:<\/strong> A 36.80x P\/E versus a 37.96x Industry P\/E shows Emcure trading almost exactly at Healthcare sector norms.<\/li>\n<li><strong>Solid ROE:<\/strong> An 18.67% ROE is a healthy figure for a diversified formulations manufacturer.<\/li>\n<li><strong>Broad export footprint:<\/strong> A presence across more than 70 export markets diversifies Emcure&#8217;s revenue base beyond India alone.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Emcure_Pharmaceuticals_Valuation_Is_It_Justified\"><\/span><strong>Emcure Pharmaceuticals Valuation: Is It Justified?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Emcure Pharmaceuticals trades almost exactly at its 37.96x Industry P\/E, with an 18.67% ROE that compares reasonably against the larger MNC pharma peers used elsewhere in this series. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/bata-india-best-stock-in-its-sector\">Is Bata India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Emcure Pharmaceuticals and other Healthcare sector stocks.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Track_Emcure_Pharmaceuticals_Before_You_Invest\"><\/span><strong>How to Track Emcure Pharmaceuticals Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Before deciding whether Emcure Pharmaceuticals deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.<\/p>\n<ol>\n<li>Open the Univest Screener and search for Emcure Pharmaceuticals to view live price, valuation ratios, and peer comparisons within the Healthcare sector.<\/li>\n<li>Compare its P\/E, P\/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.<\/li>\n<li>Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.<\/li>\n<li>Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Emcure Pharmaceuticals earns a place in the best stock in its sector conversation on the strength of a 18.67% ROE and a P\/E of 36.80x against a 37.96x Industry P\/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Is_Emcure_Pharmaceuticals_the_best_stock_in_its_sector\"><\/span><strong>Is Emcure Pharmaceuticals the best stock in its sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals has a 18.67% ROE and trades at 36.80x P\/E against a 37.96x Industry P\/E, and compares below the peer average ROE of 34.03% in this article&#8217;s named comparison, so the answer depends on what an investor is prioritising.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Emcure_Pharmaceuticals\"><\/span><strong>What is the current share price of Emcure Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals was trading at Rs 2,004.50 on the NSE as of 15 September 2026, within its 52-week range of Rs 1,260.00 to Rs 2,048.00.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Emcure_Pharmaceuticals_belong_to\"><\/span><strong>What sector does Emcure Pharmaceuticals belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals is classified under the Healthcare sector on Univest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Emcure_Pharmaceuticals_compare_to_its_sector_peers_on_PE\"><\/span><strong>How does Emcure Pharmaceuticals compare to its sector peers on P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals&#8217;s P\/E of 36.80x is above the 30.73x average of the 3 named peers compared in this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Emcure_Pharmaceuticalss_return_on_equity\"><\/span><strong>What is Emcure Pharmaceuticals&#8217;s return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals reported a return on equity of 18.67%, which is below the 34.03% average of its named peers in this comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_invest_in_Emcure_Pharmaceuticals_based_on_its_sector_position\"><\/span><strong>Should I invest in Emcure Pharmaceuticals based on its sector position?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals&#8217;s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Is Emcure Pharmaceuticals the best stock in its sector?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals has a 18.67% ROE and trades at 36.80x P\/E against a 37.96x Industry P\/E, and compares below the peer average ROE of 34.03% in this article's named comparison, so the answer depends on what an investor is prioritising.\"}},{\"@type\":\"Question\",\"name\":\"What is the current share price of Emcure Pharmaceuticals?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals was trading at Rs 2,004.50 on the NSE as of 15 September 2026, within its 52-week range of Rs 1,260.00 to Rs 2,048.00.\"}},{\"@type\":\"Question\",\"name\":\"What sector does Emcure Pharmaceuticals belong to?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals is classified under the Healthcare sector on Univest.\"}},{\"@type\":\"Question\",\"name\":\"How does Emcure Pharmaceuticals compare to its sector peers on P\/E?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals's P\/E of 36.80x is above the 30.73x average of the 3 named peers compared in this article.\"}},{\"@type\":\"Question\",\"name\":\"What is Emcure Pharmaceuticals's return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals reported a return on equity of 18.67%, which is below the 34.03% average of its named peers in this comparison.\"}},{\"@type\":\"Question\",\"name\":\"Should I invest in Emcure Pharmaceuticals based on its sector position?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Is Emcure Pharmaceuticals the best stock in its sector? A data-backed look at its ROE, valuation and named Healthcare sector peer comparison.<\/p>\n","protected":false},"author":29,"featured_media":246977,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-246978","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["246977"],"rank_math_title":["Emcure Pharmaceuticals: Best Stock in Its Sector? Key Metrics"],"rank_math_description":["Is Emcure Pharmaceuticals the best stock in its sector? Check CMP, ROE, PE versus Industry PE, debt levels and peer comparisons before deciding on this Healthcare sector stock."],"rank_math_focus_keyword":["best stock in its sector"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/emcure-pharmaceuticals-best-stock-in-its-sector.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/246978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=246978"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/246978\/revisions"}],"predecessor-version":[{"id":246979,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/246978\/revisions\/246979"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/246977"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=246978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=246978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=246978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}